<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate possible differences in <z:mp ids='MP_0002546'>pupil dilation</z:mp> and light reflex in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> patients that can be attributed to the <z:hpo ids='HP_0011007'>age of onset</z:hpo> of the disease, a statistical comparison was made of <z:mp ids='MP_0002546'>pupil dilation</z:mp> and light reflex among early- and <z:hpo ids='HP_0003584'>late-onset</z:hpo> <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e>, and patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain>The subjects included 53 probable <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> outpatients, including both early-<z:hpo ids='HP_0003674'>onset</z:hpo> type (AD: n=21) and <z:hpo ids='HP_0003584'>late-onset</z:hpo> type (SD: n=32) </plain></SENT>
<SENT sid="2" pm="."><plain>They were compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (n=15), <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> patients (DS: n=6), and patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD: n=9) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects and controls were dark-eyed Japanese </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0002546'>Pupil dilation</z:mp> and light reflex were tested in 21 AD and 32 SD patients, and were compared with those in the control subjects; 6 DS and 9 VD patients </plain></SENT>
<SENT sid="5" pm="."><plain>The measured maximum increase in pupil diameter after instilling a mixture of anticholinergic and α -adrenergic stimulating drugs (Midrin-P®), in <z:mp ids='MP_0005163'>one eye</z:mp> was significantly greater in AD and DS than in the controls </plain></SENT>
<SENT sid="6" pm="."><plain>However, there was no difference among SD, VD, and controls, suggesting a stronger pupil response to these drugs in AD than in SD </plain></SENT>
<SENT sid="7" pm="."><plain>Pupil movement in response to light became significantly smaller and faster after instillation of the drugs in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>The above findings may be useful for the early detection of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>